Survival among 91 patients with MMM with LT
. | Median mos (95% confidence interval) . |
|---|---|
| All patients with LT | |
| Survival from diagnosis of MMM | 33 (27.8-47.7) |
| Survival from LT | 2.7 (1.6-3.6) |
| Supportive care only, transfusions ± hydroxyurea | |
| Survival from diagnosis of MMM | 34.5 (28.9-57.6) |
| Survival from LT | 2.1 (1.1-3.4) |
| Noninduction chemotherapy | |
| Survival from diagnosis of MMM | 27.2 (14.5-48.7) |
| Survival from LT | 2.9 (0.8-5.3) |
| Induction chemotherapy | |
| Survival from diagnosis of MMM | 32.9 (21.7-57.4) |
| Survival from LT | 3.9 (1.6-8.9) |
. | Median mos (95% confidence interval) . |
|---|---|
| All patients with LT | |
| Survival from diagnosis of MMM | 33 (27.8-47.7) |
| Survival from LT | 2.7 (1.6-3.6) |
| Supportive care only, transfusions ± hydroxyurea | |
| Survival from diagnosis of MMM | 34.5 (28.9-57.6) |
| Survival from LT | 2.1 (1.1-3.4) |
| Noninduction chemotherapy | |
| Survival from diagnosis of MMM | 27.2 (14.5-48.7) |
| Survival from LT | 2.9 (0.8-5.3) |
| Induction chemotherapy | |
| Survival from diagnosis of MMM | 32.9 (21.7-57.4) |
| Survival from LT | 3.9 (1.6-8.9) |
For all patients with LT, n = 91; for supportive care only, n = 48; for noninduction chemotherapy, n = 19; and for induction chemotherapy, n = 24.